IMM 23.0% 33.5¢ immutep limited

Ann: Positive preliminary topline results from TACTI-003 Cohort B, page-14

  1. 7,029 Posts.
    lightbulb Created with Sketch. 569
    transparent_pixel.giftransparent_pixel.gif

    Immutep: Trial Expected to Begin Mid-2024 >IMMP

    18/04/2024 10:10PM
    No story, headline only


    Previous Stories
    18/04/2024 10:10PMImmutep: IMP761 Is a LAG-3 Agonist Antibody Designed to Restore Balance to Immune System and Address Underlying Cause of Autoimmune Diseases >IMMP(headline only)
    18/04/2024 10:09PMImmutep: Centre for Human Drug Research Will Conduct Phase I Trial to Evaluate IMP761 >IMMP(headline only)
    18/04/2024 10:01PMImmutep Appoints Leading Research Institute to Conduct First-in-Human Phase I Study of IMP761(headline only)
    these things too . buying since . just bought more as im am crazy . and someone is being crazier
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
33.5¢
Change
-0.100(23.0%)
Mkt cap ! $486.6M
Open High Low Value Volume
39.0¢ 40.0¢ 23.0¢ $16.23M 50.19M

Buyers (Bids)

No. Vol. Price($)
4 704297 33.0¢
 

Sellers (Offers)

Price($) Vol. No.
33.5¢ 102135 2
View Market Depth
Last trade - 16.10pm 27/06/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.